COVID-19 Impact on Angina Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Angina Industry
1.7 COVID-19 Impact: Angina Market Trends
2 Global Angina Quarterly Market Size Analysis
2.1 Angina Business Impact Assessment - COVID-19
2.1.1 Global Angina Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Angina Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Angina Quarterly Market Size, 2019 VS 2020
3.2 By Players, Angina Headquarters and Area Served
3.3 Date of Key Players Enter into Angina Market
3.4 Key Players Angina Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Angina Segments, By Type
4.1 Introduction
1.4.1 Beta Blockers
1.4.2 Calcium Antagonists
1.4.3 Anticoagulants
1.4.4 Antiplatelet
1.4.5 Nitrates
1.4.6 ACE inhibitors
1.4.7 Ranolazine
4.2 By Type, Global Angina Market Size, 2019-2021
5 Impact of Covid-19 on Angina Segments, By Application
5.1 Overview
5.5.1 Clinics
5.5.2 Hospitals
5.5.3 Other
5.2 By Application, Global Angina Market Size, 2019-2021
5.2.1 By Application, Global Angina Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Amgen
7.1.1 Amgen Business Overview
7.1.2 Amgen Angina Quarterly Revenue, 2020
7.1.3 Amgen Angina Product Introduction
7.1.4 Amgen Response to COVID-19 and Related Developments
7.2 Taxus Cardium Pharmaceuticals
7.2.1 Taxus Cardium Pharmaceuticals Business Overview
7.2.2 Taxus Cardium Pharmaceuticals Angina Quarterly Revenue, 2020
7.2.3 Taxus Cardium Pharmaceuticals Angina Product Introduction
7.2.4 Taxus Cardium Pharmaceuticals Response to COVID-19 and Related Developments
7.3 LegoChem Biosciences
7.3.1 LegoChem Biosciences Business Overview
7.3.2 LegoChem Biosciences Angina Quarterly Revenue, 2020
7.3.3 LegoChem Biosciences Angina Product Introduction
7.3.4 LegoChem Biosciences Response to COVID-19 and Related Developments
7.4 Lee's Pharmaceutical
7.4.1 Lee's Pharmaceutical Business Overview
7.4.2 Lee's Pharmaceutical Angina Quarterly Revenue, 2020
7.4.3 Lee's Pharmaceutical Angina Product Introduction
7.4.4 Lee's Pharmaceutical Response to COVID-19 and Related Developments
7.5 Milestone Pharmaceuticals
7.5.1 Milestone Pharmaceuticals Business Overview
7.5.2 Milestone Pharmaceuticals Angina Quarterly Revenue, 2020
7.5.3 Milestone Pharmaceuticals Angina Product Introduction
7.5.4 Milestone Pharmaceuticals Response to COVID-19 and Related Developments
7.6 Juventas Therapeutics
7.6.1 Juventas Therapeutics Business Overview
7.6.2 Juventas Therapeutics Angina Quarterly Revenue, 2020
7.6.3 Juventas Therapeutics Angina Product Introduction
7.6.4 Juventas Therapeutics Response to COVID-19 and Related Developments
7.7 ViroMed
7.7.1 ViroMed Business Overview
7.7.2 ViroMed Angina Quarterly Revenue, 2020
7.7.3 ViroMed Angina Product Introduction
7.7.4 ViroMed Response to COVID-19 and Related Developments
7.8 Kuhnil Pharmaceutical
7.8.1 Kuhnil Pharmaceutical Business Overview
7.8.2 Kuhnil Pharmaceutical Angina Quarterly Revenue, 2020
7.8.3 Kuhnil Pharmaceutical Angina Product Introduction
7.8.4 Kuhnil Pharmaceutical Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Angina Assessment
Table 9. COVID-19 Impact: Angina Market Trends
Table 10. COVID-19 Impact Global Angina Market Size
Table 11. Global Angina Quarterly Market Size, 2020 (US$ Million)
Table 12. Global Angina Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 13. Global Angina Market Growth Drivers
Table 14. Global Angina Market Restraints
Table 15. Global Angina Market Opportunities
Table 16. Global Angina Market Challenges
Table 17. By Players, Angina Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 18. Key Players, Angina Revenue Market Share, 2019 VS 2020 (%)
Table 19. Key Angina Players Headquarters and Area Served
Table 20. Date of Key Players Enter into Angina Market
Table 21. Key Players Angina Product Type
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. By Players, Global Angina Market Size 2019-2021, (US$ Million)
Table 24. Global Angina Market Size by Application: 2019-2021 (US$ Million)
Table 25. Global Angina Market Size by Region, 2019-2021 (US$ Million)
Table 26. By Country, North America Angina Market Size, 2019-2021 (US$ Million)
Table 27. By Type, US Angina Market Size, 2019-2021 (US$ Million)
Table 28. By Application, US Angina Market Size, 2019-2021 (US$ Million)
Table 29. By Type, Canada Angina Market Size, 2019-2021 (US$ Million)
Table 30. By Application, Canada Angina Market Size, 2019-2021 (US$ Million)
Table 31. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 32. By Country, Europe Angina Market Size, 2019-2021 (US$ Million)
Table 33. By Type, Germany Angina Market Size, 2019-2021 (US$ Million)
Table 34. By Application, Germany Angina Market Size, 2019-2021 (US$ Million)
Table 35. By Type, France Angina Market Size, 2019-2021 (US$ Million)
Table 36. By Application, France Angina Market Size, 2019-2021 (US$ Million)
Table 37. By Type, UK Angina Market Size, 2019-2021 (US$ Million)
Table 38. By Application, UK Angina Market Size, 2019-2021 (US$ Million)
Table 39. By Type, Italy Angina Market Size, 2019-2021 (US$ Million)
Table 40. By Application, Italy Angina Market Size, 2019-2021 (US$ Million)
Table 41. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 42. By Region, Asia-Pacific Angina Market Size, 2019-2021 (US$ Million)
Table 43. By Type, China Angina Market Size, 2019-2021 (US$ Million)
Table 44. By Application, China Angina Market Size, 2019-2021 (US$ Million)
Table 45. By Type, Japan Angina Market Size, 2019-2021 (US$ Million)
Table 46. By Application, Japan Angina Market Size, 2019-2021 (US$ Million)
Table 47. By Type, South Korea Angina Market Size, 2019-2021 (US$ Million)
Table 48. By Application, South Korea Angina Market Size, 2019-2021 (US$ Million)
Table 49. By Type, India Angina Market Size, 2019-2021 (US$ Million)
Table 50. By Application, India Angina Market Size, 2019-2021 (US$ Million)
Table 51. By Type, ASEAN Angina Market Size, 2019-2021 (US$ Million)
Table 52. By Application, ASEAN Angina Market Size, 2019-2021 (US$ Million)
Table 53. By Type, Latin America Angina Market Size, 2019-2021 (US$ Million)
Table 54. By Application, Latin America Angina Market Size, 2019-2021 (US$ Million)
Table 55. By Type, Middle East and Africa Angina Market Size, 2019-2021 (US$ Million)
Table 56. By Application, Middle East and Africa Angina Market Size, 2019-2021 (US$ Million)
Table 57. Amgen Business Overview
Table 58. Amgen Angina Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. Amgen Angina Product
Table 60. Amgen Response to COVID-19 and Related Developments
Table 61. Taxus Cardium Pharmaceuticals Business Overview
Table 62. Taxus Cardium Pharmaceuticals Angina Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Taxus Cardium Pharmaceuticals Angina Product
Table 64. Taxus Cardium Pharmaceuticals Response to COVID-19 and Related Developments
Table 65. LegoChem Biosciences Business Overview
Table 66. LegoChem Biosciences Angina Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. LegoChem Biosciences Angina Product
Table 68. LegoChem Biosciences Response to COVID-19 and Related Developments
Table 69. Lee's Pharmaceutical Business Overview
Table 70. Lee's Pharmaceutical Angina Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Lee's Pharmaceutical Angina Product
Table 72. Lee's Pharmaceutical Response to COVID-19 and Related Developments
Table 73. Milestone Pharmaceuticals Business Overview
Table 74. Milestone Pharmaceuticals Angina Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Milestone Pharmaceuticals Angina Product
Table 76. Milestone Pharmaceuticals Response to COVID-19 and Related Developments
Table 77. Juventas Therapeutics Business Overview
Table 78. Juventas Therapeutics Angina Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Juventas Therapeutics Angina Product
Table 80. Juventas Therapeutics Response to COVID-19 and Related Developments
Table 81. ViroMed Business Overview
Table 82. ViroMed Angina Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. ViroMed Angina Product
Table 84. ViroMed Response to COVID-19 and Related Developments
Table 85. Kuhnil Pharmaceutical Business Overview
Table 86. Kuhnil Pharmaceutical Angina Revenue (US$ Million), (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. Kuhnil Pharmaceutical Angina Product
Table 88. Kuhnil Pharmaceutical Response to COVID-19 and Related Developments
List of FiguresFigure 1. Angina Product Picture
Figure 2. Angina Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Angina Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Angina Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Angina Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Angina Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Angina Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Angina Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Angina Market Size Market Share, 2019-2021